Segmentation by type classifies AI systems according to underlying computational methodology, which determines development cost, regulatory pathway and scalability. Machine‑learning (ML) models, including supervised and unsupervised algorithms, represent the broadest category (≈40 % of market value) because they are applicable across diagnosis, risk stratification and operational optimization, and can be deployed on generic cloud infrastructure. Deep‑learning (DL) architectures, primarily convolutional and transformer networks, account for roughly 25 % of revenue, driven by their superior performance in image and signal processing tasks such as radiology interpretation and ECG analysis, albeit requiring specialized GPUs and larger data sets. Natural‑language‑processing (NLP) solutions (≈15 %) extract clinical insights from unstructured text, supporting coding automation, patient‑portal chatbots and literature mining, and attract premium licensing due to domain‑specific language models. Computer‑vision (CV) tools (≈10 %) focus on real‑time video analytics for surgery assistance and remote monitoring, creating hardware‑software bundles. Expert‑system and rule‑based platforms (≈5 %) remain relevant for guideline‑compliant decision support in low‑resource settings. Finally, robotic‑process‑automation (RPA) integrations (≈5 %) streamline office functions, extending AI value beyond clinical care. The proportional revenue contribution of each type reflects its maturity, data requirements and scrutiny, shaping the market taxonomy.
